On a snapshot day in 2010 there were 46,078 clients who received pharmacotherapy for opioid dependence, of which almost two in three were male. This was an overall increase of just over 2,600 clients since 2009. This was accompanied by a rise in the number of prescribers from 1,435 in 2009 to 1,449 in 2010, with the majority of prescribers in 2010 being private prescribers (80%). Consistent with previous years, in 2010 methadone accounted for close to seven in 10 clients' pharmacotherapy type, with the remaining three in 10 clients receiving either buprenorphine or buprenorphine-naloxone.
ISSN 1447-6746; ISBN 978-1-74249-174-5; Cat. no. HSE 109; 44pp.; Internet only
Publication table of contents
- Preliminary material
- Increased use of pharmacotherapy by opioid dependent clients
- Methadone was the most common pharmacotherapy type
- Increase in prescribers
- Most opioid pharmacotherapy dosing point sites were located in pharmacies
- Body section
- What are opioids?
- What treatment is available?
- The opioid pharmacotherapy system in Australia
- Cost to clients
- The NOPSAD collection
- What is the NOPSAD collection used for?
- How data are collected by each state and territory
- Number of clients
- Pharmacotherapy type
- Client characteristics
- Sex of clients
- Age group of clients
- Aboriginal and Torres Strait Islander people
- Number of prescribers
- Prescriber type
- Clients per prescriber
- Clients per prescriber by prescriber type
- Dosing point sites
- Number of dosing point sites
- Clients per dosing point
- End matter
- Appendix 1: Additional tables
- Appendix 2: Data custodians and related data collections
- Data custodianship
- Related data collections
- List of tables
- List of figures
- List of boxes
AIHW 2011. National Opioid Pharmacotherapy Statistics Annual Data collection: 2010 report. Drug treatment series no. 12. Cat. no. HSE 109. Canberra: AIHW. Viewed 29 November 2014 <http://www.aihw.gov.au/publication-detail/?id=10737419328>.